Foster & Motley’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $747K | Buy |
958
+68
| +8% | +$53K | 0.04% | 248 |
|
|
2025
Q1 | $735K | Sell |
890
-666
| -43% | -$550K | 0.05% | 244 |
|
|
2024
Q4 | $1.2M | Buy |
1,556
+584
| +60% | +$451K | 0.08% | 202 |
|
|
2024
Q3 | $861K | Sell |
972
-150
| -13% | -$133K | 0.05% | 225 |
|
|
2024
Q2 | $1.02M | Buy |
1,122
+48
| +4% | +$43.5K | 0.07% | 199 |
|
|
2024
Q1 | $836K | Buy |
1,074
+129
| +14% | +$100K | 0.06% | 222 |
|
|
2023
Q4 | $551K | Sell |
945
-63
| -6% | -$36.7K | 0.04% | 252 |
|
|
2023
Q3 | $541K | Sell |
1,008
-83
| -8% | -$44.5K | 0.04% | 258 |
|
|
2023
Q2 | $512K | Buy |
+1,091
| New | +$512K | 0.04% | 282 |
|
|
2022
Q2 | – | Sell |
-2,243
| Closed | -$642K | – | 368 |
|
|
2022
Q1 | $642K | Buy |
+2,243
| New | +$642K | 0.05% | 240 |
|